GlassScriptPhysician profile
Janet M Nettleton
NPI 1285698720
$5,044.35
in general payments reported to CMS, 2019-2025
50 companies · $933 in 2025
The $933 reported for 2025 was more than what 81% of Therapeutic Radiology providers received nationally (typical 2025 total: $179).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $490 · 2020: $539 · 2021: $874 · 2022: $712 · 2023: $549 · 2024: $948 · 2025: $933.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,429.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $526.71 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Pfizer INC. | $365.97 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $348.82 | 2021-2025 | |
| Janssen Biotech, INC. | $211.52 | 2019-2025 | Darzalex, Rybrevant, Imbruvica |
| Astrazeneca Pharmaceuticals LP | $204.06 | 2023-2025 | Imfinzi, Enhertu, Lynparza |
| Incyte Corporation | $197.81 | 2020-2025 | Monjuvi, Zynyz |
| Tactile Systems Technology INC | $194.40 | 2019-2024 | Flexitouch Plus, Entre Plus |
| Genzyme Corporation | $187.25 | 2019-2025 | |
| Sobi, INC | $175.26 | 2022-2024 | |
| Lilly USA, LLC | $172.80 | 2021-2025 | Verzenio, Jaypirca, Retevmo |
| Takeda Pharmaceuticals U.S.A., INC. | $170.41 | 2019-2025 | Fruzaqla |
| Astellas Pharma US INC | $168.78 | 2019-2025 | Xtandi |
| Amgen INC. | $134.78 | 2019-2021 | |
| Seagen INC. | $127.09 | 2020-2022 | |
| Siemens Medical Solutions USA, INC. | $108.10 | 2021-2022 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janet Nettleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.